Enes Aydemir

ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.
ELZA-affiliated researchers publish a JCRS study on ultra-high-fluence cross-linking for allogenic corneal ring segments.
New CXL research challenges the role of oxygen in corneal cross-linking. Can oxygen-independent CXL improve keratoconus treatment? Find out how this breakthrough could change clinical practice.
“I actually heard about the ELZA Institute from my cigar dealer,” they laughed. “And Syfovre? I just Googled it and saw it was from America and very expensive.”
Here’s an overview of what ELZA’s surgeons and researchers are presenting in Barcelona this year. ELZA at ESCRS 2024.
A recent publication in TVST by ELZA’s M. Enes Aydemir et al. presents an insightful study on how performing sequential corneal cross-linking with riboflavin/UV and rose bengal/green light protocols can increase corneal digestion resistance greater than each protocol on its own.
.
.